Yujia Fang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 22, 2024
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study.
Journal: Signal transduction and targeted therapy
Published: October 11, 2024
Endogenous and exogeneous stimuli-triggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer.
Journal: Journal of nanobiotechnology
Published: May 19, 2024
Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance.
Journal: Biological procedures online
Published: June 15, 2023
Differential organ-specific tumor response to first-line immune checkpoint inhibitor therapy in non-small cell lung cancer-a retrospective cohort study.
Journal: Translational lung cancer research
Published: December 08, 2022
Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions.
Journal: Fundamental research
Published: April 15, 2022
The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research.
Journal: Frontiers in oncology
Published: January 28, 2022
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases.
Journal: Translational lung cancer research
Published: January 21, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026